HOME >> BIOLOGY >> NEWS
HPV Vaccine: What's next

Merck & Co. celebrated victory when the U.S. Food and Drug Administration advisory panel made a unanimous recommendation to the FDA to approve the first-ever vaccine to protect against women's cancer. Gardisil (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine), a vaccine developed by Merck and tested by UAB investigators, is designed to protect against human papillomavirus (HPV), the sexually transmitted virus thought to be responsible for most cervical cancers. It is being hailed as the biggest breakthrough in women's reproductive cancers since the Pap smear.

But there are still several important milestones left to conquer, says Warner Huh, M.D., gynecologic oncologist and an investigator on the Merck trials and GlaxoSmithKline's HPV vaccine clinical trials.

"The FDA advisory committee's endorsement is a major step toward protecting women from cervical cancer, and we hope to hear a final decision from the FDA by June 8," Huh said. "But more importantly, the national Advisory Committee of Immunization Practices (ACIP) will likely decide this summer whether to endorse routine vaccination with this vaccine. The ACIP's HPV vaccine workgroup is recommending vaccination for girls 11 and 12 years of age. They also will consider recommendations for older adolescents and young adults. This is the committee that will decide whether this vaccine should be part of routine vaccinations for children, like the measles, mumps and rubella or chickenpox vaccines."


'"/>

Contact: Tracy Bischoff
tracy@uab.edu
205-934-8935
University of Alabama at Birmingham
19-May-2006


Page: 1

Related biology news :

1. Whats the backscatter of your beer?
2. Whats going on in the body? Advanced time-of-flight PET takes a superior look
3. Whats in the water? Estrogenic activity documented in fish caught in Pittsburghs rivers
4. A Cross-Disciplinary Look at Scientific Truth: Whats the Law to Do?
5. Whats the difference between mice and men?
6. Ossur repeats Popular Science Best of Whats New award
7. Whats next for gene therapy? Plastic
8. Whats shaped like a pear and has two genomes? Check the pond
9. Whats nature worth? New computer models tell all
10. Anti-evolutionism in AmericaWhats ahead?
11. Ossurs Power Knee wins Popular Science magazines 2005 Best of Whats New Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/5/2019)... Calif. (PRWEB) , ... July 05, 2019 , ... ... with Microsoft to bring its patented Tractus™ Platform to governments around the world. ... bring cutting edge technology and point of care solutions to operating theatres worldwide ...
(Date:6/20/2019)... ... June 19, 2019 , ... The half-million dollars ... of America Foundation, and the possibly millions of dollars of “high priority” grants ... AD, are a “welcome affirmation” of the need to investigate more thoroughly the ...
(Date:6/16/2019)... ... , ... Emtec, Inc.®, a global IT and management consulting ... CIO at the Healthcare Industry User Group (HIUG) Interact 2019 in ... President and Chief Information Officer, Lynne Briggs, will present Versiti’s Oracle Cloud Success ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine ... Pharm: Where Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as ... Animal Pharm was recently included in the Brentwood and Pacific Palisades International ...
(Date:6/12/2019)... TOWNSHIP, N.J. (PRWEB) , ... June 12, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... with Shanghai Zillion has been signed. The agreement will grant exclusive rights for ...
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, radiation ... have led to the advent of Chimeric Antigen Receptor T (CAR T) cell therapy, ... “CARs”. The CAR enables the final product to produce chemicals in the hopes that ...
Breaking Biology Technology:
Cached News: